Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Song Wen, Congying Liu, Yanyan Li, Junhong Pan, Thiquynhnga Nguyen & Ligang Zhou. (2021) Psoriasis Exacerbates the State of Insulin Resistance in Patients with Type 2 Diabetes. Diabetes, Metabolic Syndrome and Obesity 14, pages 2389-2397.
Read now
Read now
John Fitton, Alessandro Giollo & Maya H. Buch. (2018) GP2015 as a promising therapy for rheumatoid arthritis. Expert Opinion on Biological Therapy 18:4, pages 477-481.
Read now
Read now
Vibeke Strand, Giampiero Girolomoni, Martin Schiestl, Robert Ernst Mayer, Hilke Friccius-Quecke & Mark McCamish. (2017) The totality-of-the-evidence approach to the development and assessment of GP2015, a proposed etanercept biosimilar. Current Medical Research and Opinion 33:6, pages 993-1003.
Read now
Read now
Hans-Peter Hofmann, Ulrich Kronthaler, Cornelius Fritsch, Roger Grau, Stefan O. Müller, Robert Mayer, Andreas Seidl & Antonio Da Silva. (2016) Characterization and non-clinical assessment of the proposed etanercept biosimilar GP2015 with originator etanercept (Enbrel®). Expert Opinion on Biological Therapy 16:10, pages 1185-1195.
Read now
Read now
Articles from other publishers (19)
Yuchen Zhao, Han Wang, Lin Jin, Ziwei Zhang, Lianghu Liu, Mengqi Zhou, Xianzheng Zhang & Lingling Zhang. (2024) Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases. European Journal of Pharmaceutical Sciences 192, pages 106647.
Crossref
Crossref
Barizah Malik, Iva Vokic, Thomas Mohr, Marle Poppelaars, Martin Holcmann, Philipp Novoszel, Gerald Timelthaler, Thomas Lendl, Dana Krauss, Ulrich Elling, Michael Mildner, Josef M Penninger, Peter Petzelbauer, Maria Sibilia & Agnes Csiszar. (2023)
FAM3C
/
ILEI
protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice
. EMBO Molecular Medicine 15:7.
Crossref
Crossref
Lisza Niarisessa, Anisa Nova Puspitaningrum, Arief Rahman Afief, Dyah Aryani Perwitasari, Wirawan Adikusuma, Rocky Cheung, Abdi Wira Septama & Lalu Muhammad Irham. (2023) Identification of Biological Risk Genes and Candidate Drugs for Psoriasis Vulgaris by Utilizing the Genomic Information. Borneo Journal of Pharmacy 6:2, pages 110-119.
Crossref
Crossref
Maria Letizia Musumeci, Andrea Calogero Trecarichi, Giuliana Caruso, Alice Aleo, Helga Platania & Giuseppe Micali. (2022) Long lasting response to anti‐tumor necrosis factor α agents in psoriasis: A real life experience. Dermatologic Therapy 35:12.
Crossref
Crossref
Mohamed El‐Khalawany, Ahmed H. Nouh, Ahmed S. Kadah, Maged Elsheikh & Marwa Said. (2022) Evaluation of safety and efficacy of topical 4% nicotinamide in treatment of psoriasis; among a representative sample of Egyptians (an analytical observational study). Dermatologic Therapy 35:9.
Crossref
Crossref
Katelyn Baggett, Timothy G. Brandon, Rui Xiao, Zachary Valenzuela, Lisa H. Buckley & Pamela F. Weiss. (2022) Incidence Rates of Psoriasis in Children With Inflammatory Bowel Disease and Juvenile Arthritis Treated With Tumor Necrosis Factor Inhibitors and Disease-Modifying Antirheumatic Drugs. The Journal of Rheumatology 49:8, pages 935-941.
Crossref
Crossref
Yamin Shu, Yufeng Ding, Yanxin Liu, Pan Wu, Xucheng He & Qilin Zhang. (2022) Post-Marketing Safety Concerns With Secukinumab: A Disproportionality Analysis of the FDA Adverse Event Reporting System. Frontiers in Pharmacology 13.
Crossref
Crossref
Farida Benhadou, Violette Dirix, Fanny Domont, Fabienne Willaert, Anne Van Praet, Camille Locht, Françoise Mascart & Véronique Corbière. (2021) Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment. Frontiers in Immunology 12.
Crossref
Crossref
Lisa H. Buckley, Rui Xiao, Marissa J. Perman, Andrew B. Grossman & Pamela F. Weiss. (2021) Psoriasis Associated With Tumor Necrosis Factor Inhibitors in Children With Inflammatory Diseases. Arthritis Care & Research 73:2, pages 215-220.
Crossref
Crossref
Yanyun Jiang, Wenming Wang, Xiaofeng Zheng & Hongzhong Jin. (2020) Immune Regulation of TNFAIP3 in Psoriasis through Its Association with Th1 and Th17 Cell Differentiation and p38 Activation. Journal of Immunology Research 2020, pages 1-9.
Crossref
Crossref
Samantha J. Allen & Kevin J. Lumb. 2020.
253
303
.
Sara Jiayang Li, Lourdes M. Perez-Chada & Joseph F. Merola. (2018) TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management. Journal of Psoriasis and Psoriatic Arthritis 4:2, pages 70-80.
Crossref
Crossref
Shixue Chen, Lingling Li, Fan Zhang, Yu Wang, Yi Hu & Lei Zhao. (2019) Immunoglobulin Gamma-Like Therapeutic Bispecific Antibody Formats for Tumor Therapy. Journal of Immunology Research 2019, pages 1-13.
Crossref
Crossref
Chen Li, Xia Wu, Yihan Cao, Yueping Zeng, Weihong Zhang, Shuo Zhang, Yuehua Liu, Hongzhong Jin, Wen Zhang & Li Li. (2018) Paradoxical skin lesions induced by anti-TNF-α agents in SAPHO syndrome. Clinical Rheumatology 38:1, pages 53-61.
Crossref
Crossref
Zhihang Liu, Han Liu, Pengfei Xu, Qi Yin, Yaoqun Wang, Yeboah Kwaku Opoku, Jiarui Yang, Liying Song, Xu Sun, Teng Zhang, Dan Yu, Xiangxiang Wang, Guiping Ren & Deshan Li. (2018) Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice. Biomedicine & Pharmacotherapy 108, pages 1425-1434.
Crossref
Crossref
Liyan Yue, Wei Wan, Pan Xu, Linjuan Li, Chen Wang, Yuanyuan Zhang, Heng Xu, Rukang Zhang, Junchi Hu, Wenchao Lu, Hao Jiang & Cheng Luo. 2018. Targeting Protein-Protein Interactions by Small Molecules. Targeting Protein-Protein Interactions by Small Molecules
179
211
.
Lisa M. Sedger, Charani Ranasinghe, Michael F. McDermott & Parisa Asvadi. 2017. Immunotherapy - Myths, Reality, Ideas, Future. Immunotherapy - Myths, Reality, Ideas, Future.
Stephen Wikel. 2017. Arthropod Vector: Controller of Disease Transmission, Volume 2. Arthropod Vector: Controller of Disease Transmission, Volume 2
13
29
.
Ju Yeon Ryoo, Hye-Jin Yang, Eunhee Ji & Bong Kyu Yoo. (2016) Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of Plaque Psoriasis. Annals of Pharmacotherapy 50:5, pages 341-351.
Crossref
Crossref